TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ANRO

Alto Neuroscience, Inc.

Healthcare · Biotechnology

27.50$ -10.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ANRO
Line item 2021 2022 2023 2024 2025
0.01 0.00 0.00 0.00 0.00
0.01 0.01 0.01 0.02 0.02
0.00 -0.01 -0.01 -0.02 -0.02
0.33 0.93 1.13 1.91 1.58
0.15 0.22 0.28 0.88 0.72
0.47 1.13 1.41 2.77 2.28
-0.47 -1.14 -1.41 -2.79 -2.30
– 0.00 0.05 0.06 0.09
-0.36 -1.08 -1.35 -2.50 -2.19
– – – -2.50 –
-0.36 -1.08 -1.35 -2.50 -2.19
-0.35 -1.07 -1.29 -2.53 -2.08

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?